International Myeloma Foundation
About the International Myeloma Foundation Founded in 1990, the International Myeloma Foundation (IMF) is the world’s leading organization dedicated to multiple myeloma. The IMF is steadfast in its mission: improving the quality of life of myeloma patients while working toward prevention and a cure. The IMF serves people impacted by myeloma at every stage of the disease by combining world-class research, trusted education, global advocacy, and direct support. A cornerstone of this work is the International Myeloma Working Group® (IMWG)—a network of more than 300 internationally renowned researchers and clinicians who establish the guidelines that shape how myeloma is diagnosed, treated, and managed across the globe. Through its global network of support groups, educational programs, its 24/7 generative-AI myeloma assistant Myelo®, its InfoLine staff, and its advocacy for greater healthcare access, the IMF helps people living with myeloma and their care partners navigate diagnosis, treatment, and survivorship. At the same time, the IMF ensures scientific advances translate into better care and outcomes. The IMF is driven by its vision: A world where every myeloma patient can live life to the fullest, unburdened by the disease. Learn more at www.myeloma.org or contact the IMF InfoLine at (800) 452-CURE (2873) (U.S. & Canada), +1 (818) 487-7455 (worldwide), or infoline@myeloma.org. Let’s face multiple myeloma together. We’re here with support, resources, and community.www.myeloma.org
1
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 1 mention across 1 episode found for "International Myeloma Foundation".
Oct 9, 2026
Ursula MannHOST
And this really speaks to what you just said, Anne-Marie, and the work she does bringing people together.
Ursula MannHOST
So I don't know that many people know that she also does support the International Myeloma Foundation Board of Directors.
Ursula MannHOST
And she also represents Canada within Europe.
Ursula MannHOST
And patient advocates there address key challenges where they're talking about patients facing challenges in accessing diagnosis, monitoring, treatment, care, and clinical trials.